surmount-1 tirzepatide weight loss percent 72 weeks Lilly released results for SURMOUNT-2, a trial of in people with T2D and obesity or overweight at weeks: 🔘10 mg: -13.4% BW 🔘15 mg: -15.7% BW ⭐️Important: at Tirzepatide for Obesity Treatment and

The brand says 100% of participants in their clinical testing showed measurable improvement - that's a pretty bold claim

Patients with genetic variants predisposing to B12 malabsorption or metabolism inefficiency may benefit from earlier or more aggressive supplementation, while those with robust nutrient genetics can often maintain adequate levels through diet alone during tirzepatide therapy

Work from their labs and others led to the development of novel therapeutics to control insulin secretion in Type 2 diabetes based on understanding the action of GLP1 and its metabolism by the enzyme, DPP4, leading directly to the development of the DPP-4 inhibitors for diabetes therapy

The live attenuated influenza vaccine (LAIV, nasal spray) is not recommended for people with diabetes or other underlying chronic medical conditions

10.1210/jcem-48-4-633

This is particularly beneficial for individuals with type 2 diabetes, as it can lead to better blood sugar management alongside weight loss